scispace - formally typeset
Y

Yujing Wang

Researcher at Queen's University Belfast

Publications -  12
Citations -  192

Yujing Wang is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Drug delivery & Life expectancy. The author has an hindex of 6, co-authored 12 publications receiving 130 citations. Previous affiliations of Yujing Wang include Maastricht University.

Papers
More filters
Journal ArticleDOI

A nontoxic additive to introduce x-ray contrast into poly(lactic acid). Implications for transient medical implants such as bioresorbable coronary vascular scaffolds.

TL;DR: The data show that it is possible to manufacture fully radiopaque bioresorbable coronary vascular scaffolds and this important advantage may translate into improved safety, accuracy, and clinical performance of cardiac stents.
Journal ArticleDOI

Intravaginal rings for continuous low-dose administration of cervical ripening agents

TL;DR: The VR design can be readily tailored to provide sustained or controlled release of isosorbide mononitrate and MP at rates potentially useful for cervical ripening.
Journal ArticleDOI

Latanoprost Quantification in Ocular Implants and Tissues: HPLC-Fluorescence vs HPLC-UV

TL;DR: The developed method is a robust, rapid and cost-effective alternative to liquid chromatography-mass spectrometry for routine analysis of latanoprost released from ocular implants and shows better precision, while the fluorescence detector exhibited higher robustness and greater sensitivity.
Journal ArticleDOI

A validated size exclusion chromatography method coupled with fluorescence detection for rapid quantification of bevacizumab in ophthalmic formulations.

TL;DR: The developed method had a run time of 6 min at temperature 25 °C, making it a unique validated method for rapid and cost-effective quantification of bevacizumab.
Book ChapterDOI

Long-acting drug delivery systems for ocular therapies

TL;DR: In this paper, the authors highlight the increasing need for long-acting ocular drug delivery systems and highlight some of the key approaches being taken in the current research to produce them, with a focus on the use of sustained-release formulations, which have positives and negatives depending on the target site and the conditions being treated.